The expanded 510 (k) clearance is publicly available in the FDA's 510 (k) Premarket Notification database under device number K253939.

Supplemental Clearance Opens Institutional Markets and Expands Patient Population Beyond Traditional CPAP Therapy BLACKSHEAR, GA - January 15, 2026 (NEWMEDIAWIRE) - REMSleep Holdings, Inc. (OTCQB: ...

Research also suggests untreated sleep apnea is linked to a heightened risk of Parkinsons disease, a movement disorder ...

However, if you are getting up more often than usual it could be nocturia, or frequent nighttime urination, which could have ...

(HealthDay News) — A multimodal sleep foundation model based on polysomnography data can predict the risk for multiple conditions, including death, dementia, and myocardial infarction (MI), according ...

Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

The Post Office CHF rate is around 2.5% worse than the best available provider today. Compared to the average CHF rate across all providers, The Post Office is about 0.8% better. The Post Office is ...

Background Fluid restriction is a commonly prescribed non-pharmacological intervention in the management of heart failure (HF). However, data on its efficacy and safety are scarce. Recent randomised ...